Inventor
KOPPEL GARY A
US50 patents
⚠️ This page may combine multiple inventors who share the name “KOPPEL GARY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
37 patentsUS5747524AMay 5, 1998
Cannabinoid receptor antagonists
LILLY CO ELI116 citations99
US5596106AJan 21, 1997
Cannabinoid receptor antagonists
LILLY CO ELI115 citations99
US4144232AMar 13, 1979
Substituted azetidin-2-one antibiotics
LILLY CO ELI62 citations96
US6204260B1Mar 20, 2001
Non-peptidyl vasopressin V1a antagonists
LILLY CO ELI62 citations94
US5665358ASep 9, 1997
Antibody drug-conjugates
LILLY CO ELI65 citations94
US5556623ASep 17, 1996
Antibody-drug conjugates
LILLY CO ELI43 citations94
US5272253ADec 21, 1993
Cluster conjugates of drugs with antibodies
LILLY CO ELI25 citations92
US5643573AJul 1, 1997
Antibody-drug conjugates
LILLY CO ELI31 citations91
US5759865AJun 2, 1998
Combinatorial process for synthesizing azetidinone analogs
LILLY CO ELI40 citations90
US4994558AFeb 19, 1991
Immunoglobulin conjugates
LILLY CO ELI24 citations89
US4552888ANov 12, 1985
Ascorbic acid ethers in angiogene
LILLY CO ELI54 citations87
US6610680B1Aug 26, 2003
Non-peptidyl vasopressin V1A antagonists
LILLY CO ELI14 citations83
US3992377ANov 16, 1976
3-Thio-substituted cephalosporin antibiotics
LILLY CO ELI26 citations81
US4355172AOct 19, 1982
Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives
LILLY CO ELI9 citations74
US4044000AAug 23, 1977
Substituted β-lactam antibiotics
LILLY CO ELI10 citations74
US4042585AAug 16, 1977
Process for preparation of 3-halomethylcephems
LILLY CO ELI13 citations74
US4008230AFeb 15, 1977
Process for preparing 3-hydroxy cephalosporins
LILLY CO ELI8 citations74
US3994885ANov 30, 1976
Process for etherifying β-lactam antibiotics
LILLY CO ELI12 citations74
US3962232AJun 8, 1976
7-methoxycephalosporins
LILLY CO ELI8 citations74
US3953438AApr 27, 1976
Preparation of cephalosporin ethers
LILLY CO ELI11 citations74
US4814438AMar 21, 1989
Immunoglobulin conjugates of 2',2'-difluronucleosides
LILLY CO ELI15 citations70
US4203896AMay 20, 1980
Acetoxy azetidin-2-one antibiotics via thiazolidine ring cleavage
LILLY CO ELI2 citations63
US4158004AJun 12, 1979
Process for antibiotic FR 1923 and related compounds
LILLY CO ELI4 citations63
US4048163ASep 13, 1977
Process for preparation of 7-alkoxy-3-chloromethylcephems
LILLY CO ELI2 citations63
US4045435AAug 30, 1977
Preparation of cephalosporin ethers
LILLY CO ELI2 citations63
US4038275AJul 26, 1977
Process for preparation of 3-hydroxymethylcephems
LILLY CO ELI2 citations62
US4537727AAug 27, 1985
Process for recovering 2-acetylthiomethyl-5-aminopentanoic acid
LILLY CO ELI2 citations60
US4029651AJun 14, 1977
Process for preparing 3-acyloxymethyl-2-cephem compounds
LILLY CO ELI0 citations52
US6521611B2Feb 18, 2003
Non-peptidyl vasopressin V1a antagonists
LILLY CO ELI0 citations51
US4243587AJan 6, 1981
Process for 3β-aminoazetidin-2-ones
LILLY CO ELI0 citations51
US4226767AOct 7, 1980
Intermediates for 3-aminoazetidin-2-ones
LILLY CO ELI0 citations51
US4180507ADec 25, 1979
4-Oxa 2,6 diazabicycloheptane derivatives
LILLY CO ELI0 citations51
US4127568ANov 28, 1978
Process for 3β-aminoazetidin-2-ones
LILLY CO ELI1 citations51
US4552895ANov 12, 1985
Furo[3,2-b]furan-2-(3H)-ones
LILLY CO ELI1 citations50
US4501703AFeb 26, 1985
Process for preparing 2-acetylthiomethyl-5-guanidinopentanoic acid
LILLY CO ELI0 citations50
US4048160ASep 13, 1977
Process for preparation of 7-alkoxy-3-bromomethylcephems
LILLY CO ELI0 citations42
US4012410AMar 15, 1977
2-(4-Methoxyoxazolidinone-4-yl)thiazolidine t-butyl esters
LILLY CO ELI0 citations39
REVAAX PHARMACEUTICALS LLC
8 patentsUS6627625B1Sep 30, 2003
Treatment of behavioral disorders with β-lactam compounds
REVAAX PHARMACEUTICALS LLC44 citations96
US6610681B1Aug 26, 2003
Neurotherapeutic clavulanate composition and method
REVAAX PHARMACEUTICALS LLC24 citations92
US7842683B2Nov 30, 2010
Neurotherapeutic compositions and method
REVAAX PHARMACEUTICALS LLC11 citations84
US7166626B2Jan 23, 2007
Therapeutic treatment for sexual dysfunction
REVAAX PHARMACEUTICALS LLC13 citations84
US6426342B2Jul 30, 2002
Use of β-lactamase inhibitors as neuroprotectants
REVAAX PHARMACEUTICALS LLC14 citations84
US6489319B2Dec 3, 2002
Neurotherapeutic use of carboxypeptidase inhibitors
REVAAX PHARMACEUTICALS LLC17 citations81
US7998991B2Aug 16, 2011
Neurotherapeutic treatment for sexual dysfunction
REVAAX PHARMACEUTICALS LLC1 citations52
US7833998B2Nov 16, 2010
Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions
REVAAX PHARMACEUTICALS LLC0 citations49
AZEVAN PHARMACEUTICALS INC
3 patentsUS7268125B2Sep 11, 2007
β-lactamyl vasopressin V1a antagonists
AZEVAN PHARMACEUTICALS INC19 citations90
US7119083B2Oct 10, 2006
β-Lactamyl vasopressin V1a Antagonists
AZEVAN PHARMACEUTICALS INC22 citations90
US8048874B2Nov 1, 2011
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
AZEVAN PHARMACEUTICALS INC10 citations84